Tamoxifen is widely and effectively used to treat ERα-positive breast cancer with tolerable toxicity29, and no acute toxicity for tamoxifen monotherapy or in combination with EZH2i or CDK2i was observed using the doses we have chosen. The gene discussed is ESR1; the disease is breast carcinoma.